Schematic of mechanistic mechanism by which EGFR activates YAP/TAZ (IMAGE)
Caption
Scientists from Hiroshima University and University of California, San Diego have discovered the mechanism by which EGFR activates YAP/TAZ. Their results suggest that the combination of the drug targeting YAP/TAZ with EGFR targeting therapy may be beneficial for preventing cancer recurrence and progression acquired by YAP/TAZ re-activation through unknown mechanism.
Credit
Toshinori Ando, Hiroshima University and J. Silvio Gutkind, University of California, San Diego
Usage Restrictions
News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
License
Original content